Bristol Myers Squibb, Paradigm collaborate to build new model for clinical trials
Columbus : Paradigm has announced a collaboration with Bristol Myers Squibb to build a new end-to-end clinical trial operating model across design, …
Abbott Gets CDSCO Panel Nod to Study Dydrogesterone Modified Release Tablets
New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has given its nod to drug maj…
100 MBBS Seats for 10 Lakh Population Ratio: NMC Stands by its Decision, issues statement
New Delhi: Amidst opposition, the National Medical Commission has stood by its decision to cap the number of MBBS seats in a particular State/UT by…
World Mental Health Day 2023: Advocating for Mental Health as a Universal Right- Dr Niti Sapru
As a psychiatrist with a deep commitment to mental health, I am compelled to emphasize the significance of World Mental Health Day, which has been …
Merck Keytruda met primary endpoint of disease free survival in certain patients with Muscle-Invasive Urothelial Carcinoma after surgery
Rahway : Merck, known as MSD outside of the United States and Canada, has announced that the Phase 3 AMBASSADOR (A031501) trial (KEYNOTE-123) evalua…
Akum Pharma Gets CDSCO Panel Nod to Study Cetirizine Ophthalmic Solution
New Delhi: The drug major Akum Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard …
Biocon Biologics gets Complete Response Letter from USFDA for bosimilar Insulin Aspart
Bengaluru : Biocon Biologics has announced that the U.S. Food and Drug Administration (US FDA) has issued a Complete Response Letter (CRL) for the B…
